A detailed history of Eagle Bay Advisors LLC transactions in Organon & Co. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 1,863 shares of OGN stock, worth $29,752. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,863
Previous 2,500 25.48%
Holding current value
$29,752
Previous $47,000 42.55%
% of portfolio
0.02%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$14.44 - $18.83 $9,198 - $11,994
-637 Reduced 25.48%
1,863 $27,000
Q3 2024

Oct 22, 2024

SELL
$18.65 - $23.03 $5,595 - $6,909
-300 Reduced 10.71%
2,500 $47,000
Q4 2023

Feb 08, 2024

BUY
$10.95 - $17.32 $15,329 - $24,248
1,400 Added 100.0%
2,800 $40,000
Q2 2023

Aug 10, 2023

SELL
$19.27 - $24.63 $77 - $98
-4 Reduced 0.28%
1,400 $29,000
Q1 2023

Apr 24, 2023

SELL
$21.42 - $32.08 $12,852 - $19,248
-600 Reduced 29.94%
1,404 $33,000
Q4 2022

Jan 26, 2023

BUY
$23.31 - $28.61 $6,759 - $8,296
290 Added 16.92%
2,004 $0
Q3 2022

Nov 22, 2022

BUY
$23.4 - $34.25 $5,499 - $8,048
235 Added 15.89%
1,714 $40,000
Q2 2022

Aug 19, 2022

BUY
$31.66 - $38.9 $46,825 - $57,533
1,479 New
1,479 $49.9 Million
Q1 2022

May 11, 2022

SELL
$30.45 - $39.36 $34,286 - $44,319
-1,126 Closed
0 $0
Q4 2021

Jan 21, 2022

SELL
$28.67 - $37.13 $14,076 - $18,230
-491 Reduced 30.36%
1,126 $35,000
Q3 2021

Nov 12, 2021

BUY
$28.63 - $35.64 $30,490 - $37,956
1,065 Added 192.93%
1,617 $53,000
Q2 2021

Jul 30, 2021

BUY
$28.45 - $38.0 $15,704 - $20,976
552 New
552 $21,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.06B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.